EW

Edwards Lifesciences (EW) P/E Ratio
P/E Ratio as of Nov 11, 2026: 61.62
Average54.85
Median53.89
Minimum50.60
Maximum61.62
61.62
11.06 (21.87%)past month
The P/E ratio for Edwards Lifesciences (EW) is 61.62 as of Nov 11, 2026. This represents a increase of 33.00% compared to its 12-month average P/E ratio of 46.33. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Edwards Lifesciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Edwards Lifesciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Edwards Lifesciences to industry peers.
Edwards Lifesciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Edwards Lifesciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Edwards Lifesciences to industry peers.
Edwards Lifesciences (EW) P/E Ratio Insights
See Edwards Lifesciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Edwards Lifesciences (EW)
Order type
Buy in
Order amount
Est. shares
0 shares
Edwards Lifesciences (EW) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Nov 2, 2026 | $93.26 | 54.31 |
| Oct 1, 2026 | $85.19 | 50.55 |
| Sep 1, 2026 | $90.74 | 53.85 |
| Aug 3, 2026 | $88.82 | 52.71 |
| Jul 1, 2026 | $91.99 | 49.98 |
| Jun 1, 2026 | $88.16 | 47.90 |
| May 1, 2026 | $83.98 | 45.63 |
| Apr 1, 2026 | $81.26 | 44.99 |
| Mar 2, 2026 | $87.18 | 48.26 |
| Feb 2, 2026 | $82.65 | 35.19 |
| Jan 2, 2026 | $85.33 | 36.33 |
Edwards Lifesciences (EW) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 61.62 | +69.80% |
| 2025 | 36.29 | +239.79% |
| 2024 | 10.68 | -67.24% |
| 2023 | 32.60 | +1.49% |
| 2022 | 32.12 | -40.95% |
| 2021 | 54.39 | — |
FAQs About Edwards Lifesciences (EW) P/E ratio
The latest P/E ratio of Edwards Lifesciences (EW) is 61.62, as of Nov 11, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Edwards Lifesciences’s last 12-month average P/E ratio is 46.33, compared to its current P/E ratio of 61.62. This reflects a increase of 33.00%.
Edwards Lifesciences’s current P/E ratio of 61.62 is higher than its last 12-month average P/E of 46.33. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Edwards Lifesciences’s average P/E ratio over the last 3 years is 37.04. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Edwards Lifesciences’s average P/E ratio over the last 5 years is 37.58. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Edwards Lifesciences (EW) P/E Ratio Insights
See Edwards Lifesciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Edwards Lifesciences (EW)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.